Average Co-Inventor Count = 2.54
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Velicept Therapeutics, Inc. (5 from 8 patents)
2. Vtv Therapeutics LLC (4 from 52 patents)
3. Velicept Therapeutcis, Inc. (1 from 1 patent)
4. Altherx, Inc. (1 from 1 patent)
11 patents:
1. 11096946 - Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
2. 10751311 - Compositions and methods of using modified release solabegron for lower urinary tract symptoms
3. 10668034 - Pharmaceutical compositions and the treatment of overactive bladder
4. 10456406 - Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
5. 10350182 - Pharmaceutical compositions and the treatment of overactive bladder
6. 9968613 - Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
7. 9956194 - Compositions and methods of using modified release solabegron for lower urinary tract symptoms
8. 9907767 - Pharmaceutical compositions and the treatment of overactive bladder
9. 9522129 - Pharmaceutical Combination
10. 9487493 - Use of a PPAR-delta agonist for treating muscle atrophy
11. 8642661 - Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antagonists